Anglo Asian Mining Share Discussion Threads

[riggerbeautz] 18/6/2020 08:16

Yeah he’s good, I listen to him, not a shouter or over excitable.

[callmebwana] 18/6/2020 08:15

Good morning all.
Wan,I am just an ordinary guy, I am not a good trader or an investor either.
Call it hunch,luck etc. I do,do my DYOR etc and I also make many mistakes too.
I think I have a good heart and would always stand by the underdog,so to speak. I have experienced being that in my life too.
Back to the market.
Ah' AVCT is a disruptive bio tech Co. and now I am happy to hold on to those shares. I won't be selling them anytime soon either. It is all to help mankind fight the unknown in health issues.
So as you know,I am an investor and not a trader. PUR,POG,AAZ etc are investments. Also holding cash at the moment is prudent too IMHO.
Let's see how things develop in the future for all of us. The market has a habit of tripping us at times too.
GLA and ATB. Be safe and be lucky in life.

[donald pond] 18/6/2020 08:12

On the subject of Jeremy Grantham, this podcast from the last week is the single best thing on investing I have ever heard. You listen to him and think he should be running the country:

[onedayrodders] 18/6/2020 08:11

And the 'blonde' presenter (ok she's hot) tries to imply maybe he's just bitter he missed the recent rise from the March crash !I know who my money is on !

[brasso3] 18/6/2020 07:49

If there was not a large seller in recent week ORPH would have hit 20p. It does provide a nice opportunity at 12p though.

[wanobi] 18/6/2020 07:47

yep, nice interview with ORPH Brasso3,,, thanx for posting the link, cheers Wan :-)

[wanobi] 18/6/2020 07:37

fair point pogue,,, I do sometimes get a little over excited when I first read positive RNS's :-),,, please do forgive me :-) thanx, cheers Wan :-)

[wanobi] 18/6/2020 07:35

PUR - $15 MILLION NON-BROKERED FLOW THROUGH FINANCING

Eric Sprott increases his share ownership to 12%

VANCOUVER, B.C. - June 17, 2020 - Pure Gold Mining Inc. (TSXV:PGM, LSE:PUR) ("PureGold" or the "Company") is pleased to announce that it has closed the non-brokered private placement of 9,868,421 common shares of the Company that qualified as "flow-through shares" for the purposes of the Income Tax Act (Canada) (the "FT Shares") at a price of $1.52 per FT Share (the "Financing"), for gross proceeds to PureGold of $15,000,000. Subsequent to the private placement, Mr. Eric Sprott was the back-end buyer of all of the FT Shares.

Cheers
Wan :-)

[wanobi] 18/6/2020 07:34

CORA - Cora Gold Limited, the West African focused gold company, is pleased to announce that it has signed a US$21m mandate and term sheet with investment firm, Lionhead Capital Advisors Proprietary Limited ('Lionhead'), to fund the future development of its flagship Sanankoro Gold Project ('Sanankoro' or 'the Project') in Southern Mali (the 'Project Financing'). This is conditional on, among other matters, the completion of a Definitive Feasibility Study ('DFS') on the Project before the end of 2021.

Cheers
Wan :-)

[wanobi] 18/6/2020 07:32

NCYT also RNS'ed today,, Novacyt S.A. Three new products to support COVID-19 testing...... and the game goes on :-) LOL Cheers Wan :-)

[pogue] 18/6/2020 07:31

Wan
There are over 20 serious contenders for a CV19 vaccine, over 200 in total I believe, AVCT have a long way to catch up on them and maybe too late to market. The cost of developing the vaccine is large as well hence the request for a partner to pay for it all but as I said plenty of other contenders out there so crowded market to be looking for a partner.

[wanobi] 18/6/2020 07:26

many thanx pogue,,, wowzer AVCT might find a cure to cv19 at this rate... I predict a bit of a rise in AVCT share price today,,, we shall see GLA Holders, cheers Wan :-)

Infectivity assays carried out in collaboration with Glasgow University show that Affimer reagents prevent infection of human cells by a SARS-COV-2 model virus...

Neutralising therapies could be given to those exposed to the virus, such as health and social-care workers, to prevent infection, as well as to patients already infected by the virus, to help treat and prevent disease progression. There is ongoing significant investment by large pharmaceutical companies such as AstraZeneca, GSK, Boehringer Ingelheim and others to develop neutralising therapies for COVID-19.

Given the excellent performance of these novel reagents in the assays, and the other benefits of Affimer reagents, there should be considerable interest from potential partners in developing them as a therapy for COVID-19.

This is critical information that will help to establish a license deal with a large pharmaceutical partner that has the resources to carry out an accelerated clinical development programme.

[wanobi] 18/6/2020 07:23

many thanx Stig - i do like the way the chart has shaped up :-) Cheers Wan :-)


free stock charts from uk.advfn.com



free stock charts from uk.advfn.com



free stock charts from uk.advfn.com

[wanobi] 18/6/2020 07:16

many thanx for those kind words cmb,,, its been an absolute pleasure to have engaged and learnt from you over the past 23 months,,,, my second birthday is approaching fast :-) LOL and I will celebrate it :-),,, what a ride its been,,, all those discussions around black swans and hey presto, one of the biggest ones arrives,,, oh what a game cmb,,, indeed, oh what a life we live on this planet!!!,,, hope things are going ok for you over in Cyprus and wishing you the very best of health and happiness.. :-) Cheers Wan :-)

[pogue] 18/6/2020 07:11

AVCT RNS, not a big one but a good one it confirms affimers can block SARS-COV-2 from binding to human cells.



Update on Affimer(R) Therapy for COVID-19 Infection
Infectivity assays carried out in collaboration with Glasgow University show that Affimer reagents prevent infection of human cells by a SARS-COV-2 model virus
Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that Affimer reagents which bind to the SARS-COV-2 virus spike protein prevent infection of human cells by a SARS-COV-2 model virus and therefore provide a potential therapy for COVID-19 infection.........
The infectivity assays that we have carried out with the Affimer reagents have gone very well and they show that there are a number of them that are potent inhibitors of a SARS-COV-2 model virus entry into human cells.
Given the excellent performance of these novel reagents in the assays, and the other benefits of Affimer reagents, there should be considerable interest from potential partners in developing them as a therapy for COVID-19."

[wanobi] 18/6/2020 07:10

Good morning all, good health and Good luck today, Cheers Wan :-)

[the stigologist] 17/6/2020 20:03

For newbies an old post by an ex-Founder of Physiomics PYC expressing his opinion the stock is worth over 100p per share AND the justification for that VALUE by explaining the Industry dynamics and Physiomics significant assets and standing in this Industry.

-------------------------------------------------------

Writing as a Founder of Physiomics

I am a shareholder but do not represent the company in any capacity.

WHY THIS SHARE IS WORTH A £1.00 giving it a market cap of still less than £60.million

*It is first to market

*Scarcity of trained personnel in what is still an emergent technology ( there are currently over a 1000 vacancies to be filled in this sector and few trained personnel )

*The development time needed to populate models and most importantly the availability of patient data that needs to be accessed apart from what is available in the literature is protracted PYC has been through this curve perfecting its models over time.

* The Biometric Grant serves to demonstrate not only the faith in the company but also underpins the access PYC is being given to Patient data In this case in the field of Oesophgeal Cancer

*Collaborations with major pharmas have been constrained whilst the models are perfected and due to the secretive nature of all pharmas who generally speaking do not want to share data. The latest contract has dramatically increased the visibility of what PYC do and do best and will encourage a raft of Biotech analysts to write it up as more contracts are announced

*PYC's Cardiac Toxicity Model is 50% plus better than any other available on the market Why is this important? it is the major cause of attrition in clinical trials
( drug failure )

*The cost savings PYC is able to realise for major Pharma is key and further to small Biotechnology companies whose funding is limited as they try to move molecules into clinical trials.

* Big Pharmas feed their development pipelines by acquiring or licensing in small bio's however these sales have moved progressively from Targets 20 years ago to IND candidates and onto Phase 1/2 putting the burden of proof onto the small Bio Techs who need to conserve and raise cash ( not easy and never has been )

*In 2010 Scientific American stated the cost of Development of a drug from start to finish FDA approval was $1.4 billion...In 2016 Association of British Pharmaceutical Industry Has upped this to £1.5 billion ( sterling) a really significant increase. NOTING that only 1 in 5000 drugs get final approval and this is not factored into the costs as above as representing only a successful transition of 1 drug to approval

*In America alone $12-%14 billion per year is spent on Animal Testing Robert Solari a senior research fellow at Imperial College states "The predictive power of biology in reseach is relatively poor in research labs" and notes that the efficacy of animal testing are not particulary predictive of Human Efficacy PYC is "in Silico" ( in computer) its accuracy is one of its major plus points

* PYC is striving to personalised medicine The HOLY GRAIL with tremendous Social and Financial Implications.

* Sooner rather than later The FDA in America will have to recognise that rational drugs designed in computers can be tested in them too saving countless millions of development costs and most importantly time taken to approval ie move from the 20 to the 21st century

* PYC has taken time to develop its excellent technology I believe I have cited the reasons for its true value. It has been challenged in recent times but has now become of age an is exceptionally well positioned in a market sector that is set to expand exponentially.

To recap A leading British Technology currently way undervalued and one that is not a speculative BUY It has proven technology in a burgeoning sector and might well become the focus of an acquisition target as it is still so undervalued

[callmebwana] 17/6/2020 19:38

Bumpa good to see you back here.

Wan,I am no longer keeping an eye on your trading at all. LOL,you are way past the novice investor. Now you handle things your way. You have been an exceptional learner and I lift my hat to you sir.
You manage this BB thread with exceptional patience. I genuinely wish you all the best in life and also your investments.
ATB.

[droyden] 17/6/2020 19:36

They will need some sort of quick test to allow a much more relaxed freedom of movement

[pogue] 17/6/2020 19:09

Interesting note on the BBC webpage regarding testing fans to allow them into football games, AVCT shareholders read on...



Fans will not be allowed back into grounds to watch any of the remaining Premier League matches and potentially into the start of next season while government guidelines on mass gatherings remain in place.
But former sports minister Richard Caborn has suggested smaller crowds could be permitted at some fixtures even if a vaccine isn't found.
"I understand discussions are ongoing with some Premier League clubs to see whether they can start using testing, but also digital passports as well," Caborn told BBC Radio 4's Today Programme.
"There are some British companies working with the clubs, both on testing and there's obviously some fairly advanced technology."
Digital passport technology is currently used by the United Nations to monitor infection rates.

[riggerbeautz] 17/6/2020 17:43

Correct Wan

[wanobi] 17/6/2020 17:43

thanx Rb,,,, what's that saying "over analysis leads to paralysis' :-) LOL Cheers Wan :-)

[riggerbeautz] 17/6/2020 17:41

So true Bumpa, our posts crossed ;)

Erm think it may be more than 4 lol

[wanobi] 17/6/2020 17:41

thanx Bumpa,,, no need to apologise at all :-),,,, I've taken the plunge on EVG,,, but, honestly,,, I have done absolutely zero research,,, other than to post the chart highlighting the incredible volume today!!! all very intriguing :-) LOL, cheers Wan :-)